🇺🇸 FDA
Patent

US 11718630

Compositions and methods for treating cancer

granted A61KA61K38/1709A61P

Quick answer

US patent 11718630 (Compositions and methods for treating cancer) held by The Regents of the University of California expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K38/1709, A61P, A61P35/00, A61P35/02